Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $110.3600 (1.22%) ($107.7200 - $110.9000) on Wed. Sep. 8, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.28% (three month average) | RSI | 33 | Latest Price | $110.3600(1.22%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -1.8% a day on average for past five trading days. | Weekly Trend | ABBV declines -3.4% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(43%) SPLV(35%) VYM(32%) XLP(32%) DIA(31%) | Factors Impacting ABBV price | ABBV will decline at least -0.64% in a week (0% probabilities). VIXM(-20%) UUP(-10%) VXX(-1%) TLT(-1%) KWEB(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.64% (StdDev 1.28%) | Hourly BBV | 0.6 () | Intraday Trend | 2.2% | | | |
|
Resistance Level | $116.6 | 5 Day Moving Average | $111.06(-0.63%) | 10 Day Moving Average | $115.44(-4.4%) | 20 Day Moving Average | $116.6(-5.35%) | To recent high | -8.6% | To recent low | 1.2% | Market Cap | $194.706b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |